Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Harran University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Harran University as lead sponsor. Synced 12 Nov 2026
13Current trials
7Recruiting now
0Drugs in these trials
1Trial register
At a glance

Harran University is the lead sponsor of 13 current clinical trials in our Turkey register. 7 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).

ClinicalTrials.gov trials by status

  • Recruiting754%
  • Not yet open323%
  • Active, closed215%
  • By invitation18%

Trials by phase

  • Not applicable754%
  • Observational646%
01

Clinical trials sponsored by Harran University

13 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Metabolic and Immunologic Biomarkers in Chronic Rhinosinusitis With Nasal Polyps
NCT07860411 · ClinicalTrials.gov ↗ · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Nasal Polyps
Observational Recruiting 2026-03 Turkey
Serum and Salivary Leptin Levels in Children With Adenoid/Adenotonsillar Hypertrophy
NCT07887451 · ClinicalTrials.gov ↗ · Adenoid Hypertrophy, Adenotonsillar Hypertrophy
Observational Recruiting 2026-03 Turkey
Evaluation of the Effect of Tea Tree and Chlorhexidine Mouthwashes on Healing After Third Molar Extraction
NCT07180498 · ClinicalTrials.gov ↗ · Postoperative Pain, Postoperative Complications, Trismus
Not applicable Recruiting 2025-04 Turkey
Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery
NCT07290881 · ClinicalTrials.gov ↗ · Acute Pain
Not applicable Recruiting 2026-04 Turkey
Effectiveness of Ventilation Modes in Intensive Care: A Comparison of Mandatory Minute Ventilation and Synchronized Intermittant Mandatory Ventilation Using Bioelectrical Impedance Tomography
NCT06961227 · ClinicalTrials.gov ↗ · Ventilation Modes, Mechanical Ventilation, Critical Illness
Observational Recruiting 2025-03 Turkey
Detection of Disease Marker Factors in Cyst Fluid
NCT07171151 · Biomarkers
Observational Recruiting 2025-08 Turkey
Alpha-Tectorin, Interleukin-10 and Thiol-Disulfide Homeostasis in Children With Congenital Hearing Loss
NCT07860580 · ClinicalTrials.gov ↗ · Congenital Hearing Loss, Sensorineural Hearing Loss
Observational Recruiting 2026-04 Turkey
Impact of Post-Cesarean Abdomino-Pelvic Training on Diastasis Recti and Sexual Function
NCT07575490 · ClinicalTrials.gov ↗ · Diastasis Recti Abdominis Postpartum Period Cesarean Section Sexual Dysfunction, Physiological Pelvic Floor Muscle Training
Not applicable Not yet open 2026-05 Turkey
Investigation of the Effects of Basic Body Awareness Training on Motor Skills İn Children at Risk of Developmental Delay
NCT07054996 · ClinicalTrials.gov ↗ · Developmental Delay, Body Perception
Not applicable Not yet open 2025-07 Turkey
Adaptation of the Intensive Care Unit-specific Pressure Injury Risk Scale to Turkish (RAPS-ICU)
NCT06908512 · ClinicalTrials.gov ↗ · Pressure Injury, Reliability and Validity, Intensive Care Units (ICUs)
Observational Not yet open 2025-03 Turkey
The Effect of Breathing Exercise and Pressurized Cold Application on Pain and Anxiety During Sharp Debridement
NCT06886633 · ClinicalTrials.gov ↗ · Diabetic Foot Ulcer
Not applicable By invitation 2025-03 Turkey
The Effect of Education Given to Patients With Heart Failure on Self-care, Drug Compliance and Quality of Life.
NCT05418478 · ClinicalTrials.gov ↗ · Heart Failure
Not applicable Active, closed 2022-06 Turkey
Assessment of Masseter Muscle With Ultrasonography
NCT06734559 · ClinicalTrials.gov ↗ · Acute Apical Periodontitis of Pulpal Origin
Not applicable Active, closed 2025-01 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Harran University trials

26 conditions
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)1Nasal Polyps1Adenoid Hypertrophy1Adenotonsillar Hypertrophy1Postoperative Pain1Postoperative Complications1Trismus1Periodontal Health1Acute Pain1Ventilation Modes1Mechanical Ventilation1Critical Illness1Respiratory Support1Heart Failure1Acute Apical Periodontitis of Pulpal Origin1Biomarkers1Diastasis Recti Abdominis Postpartum Period Cesarean Section Sexual Dysfunction, Physiological Pelvic Floor Muscle Training1Developmental Delay1Body Perception1Pressure Injury1Reliability and Validity1Intensive Care Units (ICUs)1Assessment Scale1Diabetic Foot Ulcer1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey137

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

SponsorTrials
Beijing Tongren Hospital2

Sponsors with the most current trials registered for this condition.

05

Questions about Harran University trials

How many clinical trials does Harran University sponsor?

Harran University is the lead sponsor of 13 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Harran University trials recruiting?

Yes. 7 of its 13 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.